Search results
Author(s):
Keith C Ferdinand
Added:
3 years ago
Heart failure is a major health concern in the US and is particularly problematic in the African-American community where the disease has an earlier onset and exhibits increased mortality, even with hospitalisation. Early onset is manifested primarily in middle-aged patients, where the rates of heart failure are higher than that with a higher mortality than in whites. Between the ages of 45 and…
View more
Author(s):
Moussa Mansour
Added:
3 years ago
Dr Moussa Mansour (Massachusetts General Hospital, Boston, MA, US) shares updates from the PRECEPT Study.
The objective of the Persistent atrial fibrillation ablation with contact force sensing catheter: The prospective multicenter PRECEPT Trial is to evaluate the safety and effectiveness of catheter ablation of PsAF using a porous tip contact force (CF)-sensing catheter.
Questions:
1.What are…
View more
Author(s):
Edwin E Ferguson
Added:
3 years ago
Cardiac rehabilitation (CR) refers to coordinated multifaceted interventions designed to optimize a cardiac patient's physical, social, and psychological functioning, with the additional goals of stabilizing, slowing, or even reversing the progression of the underlying atherosclerotic processes, thereby reducing morbidity and mortality.1CR is a comprehensive secondary prevention program that…
View more
HFA 2023: Late-Breaking Science Video Collection
Video Series
Mary McDermott
Author
Author(s):
Mirvat Alasnag
Added:
4 months ago
TCT 23 - We are joined by Dr Mirvat Alasnag (The King Fahd Armed Forces Hospital, SA) for an insightful summary of the late-breaking trials that are expected to have an impact on interventional science and clinical practice.
Trials covered in detail include:
Agent IDE
ALIGN-AR
PARTNER 3
EVOLUT Low-Risk
TRISCEND
Recorded remotely from Jeddah, 2023.
Editor: Jordan Rance
Video Specialist:…
View more
Author(s):
Edwin E Ferguson
Added:
3 years ago
Cardiac rehabilitation (CR) refers to coordinated multifaceted interventions designed to optimize a cardiac patient's physical, social, and psychological functioning, with the additional goals of stabilizing, slowing, or even reversing the progression of the underlying atherosclerotic processes, thereby reducing morbidity and mortality. CR is a comprehensive secondary prevention program that…
View more
Author(s):
Harriette Van Spall
,
James L Januzzi
Added:
10 months ago
ESC-HFA 2023 – Late-breaker host, Dr Harriette Van Spall (McMaster University, CA) joined by Dr James Januzzi (Massachusetts General Hospital, US) to discuss late-breaking science highlights of this year's ESC Heart Failure.
Trials covered in details include:
1:13: First-in-Human Study of NI006 in Patients With Amyloid Transthyretin Cardiomyopathy
1:42: TRACER-HF:Trientine-HCL for treatment of…
View more
Author(s):
Zvonimir Krajcer
Added:
3 years ago
Annually, in the US approximately 15,000 deaths are caused by a rupture of an abdominal aortic aneurysm (AAA), making it the 13th leading cause of death. AAA is often referred to as ‘the silent killer’ and is estimated to affect 2.7 million Americans, half of whom are not correctly diagnosed.1 If left untreated, the risk of rupture is 80–90% through progressive thinning of the aortic vessel,…
View more
Author(s):
Harriette Van Spall
,
Clyde W Yancy
Added:
9 months ago
Join Masterclass host, Dr. Harriette Van Spall (McMaster University, CA), in an in-depth interview with Dr. Clyde W. Yancy (Northwestern University, US).
Dr. Yancy, an internationally respected leader and mentor in cardiology, holds positions as the Vice Dean of Diversity and Inclusion, Magerstadt Professor of Medicine, and Chief of the Division of Cardiology at Northwestern University's…
View more